COPD患者戒烟的变化与临床结局:CHAIN队列前瞻性分析
多数患者维持原吸烟习惯,基线慢性咳痰是未来持续戒烟的最相关识别变量,焦虑总分是与戒烟最相关的临床因素。
要点
- 真实世界COPD队列无特定戒烟干预时,多数患者2年内吸烟状态未改变。
- 基线慢性咳痰是识别未来持续戒烟者的最重要变量。
- 焦虑总分是与戒烟最相关的临床因素,其次为LCADL评分。
核心结论
- 在无特定戒烟干预的真实世界COPD队列中,多数患者吸烟状态未改变。
- 基线咳痰、焦虑和日常活动呼吸困难是COPD吸烟状态的主要决定因素。
研究设计与样本
- CHAIN为西班牙多中心研究,在呼吸专科门诊纳入吸烟和已戒烟的COPD患者。
- 吸烟状态由临床病史和血氧饱和仪测定确认,未实施特定戒烟干预。
- 随访2年,第2次访视906例,第3次访视791例。
主要发现
- 随访2年期间,大多数患者维持相同的吸烟习惯。
- 决策树分析显示慢性咳痰是识别未来持续戒烟者的最相关变量。
- 决策树分析中,LCADL问卷(界值9分)也是识别持续戒烟者的相关变量。
- 与戒烟最相关的临床因素为HADS焦虑总分,其次为LCADL问卷(界值10分)。
关键数值与推荐
- 识别持续戒烟者的决策树变量:慢性咳痰,LCADL问卷界值9分。
- 与戒烟相关的临床因素:HADS焦虑总分,LCADL问卷界值10分。
临床怎么用
- 对COPD患者应关注基线慢性咳痰、焦虑和日常活动呼吸困难,这些因素与吸烟状态相关。
- 可考虑使用LCADL问卷评估日常活动能力,辅助识别戒烟可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the existing evidence-based smoking cessation interventions, chances of achieving that goal in real life are still low among patients with COPD. We sought to evaluate the clinical consequences of changes in smoking habits in a large cohort of patients with COPD. METHODS: CHAIN (COPD History Assessment in Spain) is a Spanish multicenter study carried out at pulmonary clinics including active and former smokers with COPD. Smoking status was certified by clinical history and co-oximetry. Clinical presentation and disease impact were recorded via validated questionnaires, including the London Chest Activity of Daily Living (LCADL) and the Hospital Anxiety and Depression Scale (HADS). No specific smoking cessation intervention was carried out. Factors associated with and clinical consequences of smoking cessation were analyzed by multivariate regression and decision tree analyses. RESULTS: One thousand and eighty-one patients with COPD were included (male, 80.8%; age, 65.2 [SD 8.9] years; FEV1, 60.2 [20.5]%). During the 2-year follow-up time (visit 2, 906 patients; visit 3, 791 patients), the majority of patients maintained the same smoking habit. Decision tree analysis detected chronic expectoration as the most relevant variable to identify persistent quitters in the future, followed by an LCADL questionnaire (cutoff 9 points). Total anxiety HADS score was the most relevant clinical impact associated with giving up tobacco, followed by the LCADL questionnaire with a cutoff value of 10 points. CONCLUSIONS: In this real-life prospective COPD cohort with no specific antismoking intervention, the majority of patients did not change their smoking status. Our study also identifies baseline expectoration, anxiety, and dyspnea with daily activities as the major determinants of smoking status in COPD. TRIAL REGISTRY: ClinicalTrials.gov; No. NCT01122758; URL: www.clinicaltrials.gov.
引用
- Martínez-González C, Casanova C, de-Torres JP, et al. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort. Chest. 2018. PMID: 29476876. doi:10.1016/j.chest.2018.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。